---
title: "Chasing AI’s value in life sciences"
date: "2024-10-31"
source: "MIT Technology Review"
sourceUrl: "https://www.technologyreview.com/2024/10/31/1106332/chasing-ais-value-in-life-sciences/"
excerpt: "Inspired by an unprecedented opportunity, the life sciences sector has gone all in on AI. For example, in 2023, Pfizer introduced an internal generative AI plat..."
---

# Chasing AI’s value in life sciences

<div class="text-sm text-gray-500 mb-4">
  Published on October 31, 2024 | Source: [MIT Technology Review](https://www.technologyreview.com/2024/10/31/1106332/chasing-ais-value-in-life-sciences/)
</div>

Inspired by an unprecedented opportunity, the life sciences sector has gone all in on AI. For example, in 2023, Pfizer introduced an internal generative AI platform expected to deliver $750 million to $1 billion in value. And Moderna partnered with OpenAI in April 2024, scaling its AI efforts to deploy ChatGPT Enterprise, embedding the tool’s…

---

*This article was originally published on [MIT Technology Review](https://www.technologyreview.com/2024/10/31/1106332/chasing-ais-value-in-life-sciences/). Visit the source for more information.*
